Shanshan Ma

1PUBLICATIONS
5CO-AUTHORS
Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 04, 2026
A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.

Wanyue Zhao, Ling Li, Xiaorui Fu

Pageof 1

Frequent Collaborators

1 joint publications

Wanyue Zhao

1 joint publications

Honghan Qiao

1 joint publications

Qingjiang Chen

1 joint publications

Mingzhi Zhang